Russia has arrived in the global vaccination race. According to a new peer-reviewed study released Tuesday, the country’s two-shot Sputnik V vaccine has been shown to be 91.6 percent effective against symptomatic COVID-19 and fully effective against severe cases. There had been a lot of skepticism about Russia’s shot, which was approved by the Russian authorities in August, due to its incredibly rapid development and a lack of reliable published trial data. But the findings, which came as a result of a large-scale clinical trial published in the British medical journal the Lancet, it will help dispel that doubt. Its efficacy is comparable to Western vaccines developed by Moderna and Pfizer / BioNTech. The Sputnik V has already been given to more than two million people around the world, including in Argentina, Serbia and Algeria. It does not require special freezer refrigeration.
Read it up Wall Street Journal